Agilent's new 5987A GC/MS takes aim at costly sample reruns

A failed quality control batch on a GC/MS system gets paid for twice. Sharon Dong of Lab Manager laid out the math in her Nov. 10 review of Agilent Technologies' new 5987A GC/MSD. The lab pays once for the rerun itself, then again for the carrier gas and instrument hours that rerun consumes. That second cost has climbed this year. The review's editor's note says helium spot prices doubled within weeks of the March 2026 supply disruption.

Agilent's new single quadrupole mass spectrometer is built around that problem. It pairs faster scanning and a wider detector range with GC Assist, a built-in diagnostics layer, plus acquisition software that folds separate runs into one. Lab Manager notes the launch comes as labs weigh replacement cycles against tighter capital budgets, which puts diagnostics and energy draw into the purchase math. A lab manager replacing an aging detector can buy another conventional single quad or pay for one that monitors itself. The deciding number sits in the lab's own logs: how many of last year's reruns would the new system have prevented?

Where the second injection comes from

Over-range samples are one source of extra injections. Lab Manager compared this with previous-generation practice, where an over-range sample on an older single quadrupole GC/MSD has to be diluted and reinjected. Agilent says the Extended Range detector on the 5987A widens dynamic range by an order of magnitude. If that claim holds up in daily work, one calibration can cover both trace-level and high-concentration analytes, and no dilution rerun is needed. Agilent also says the same detector triples electron multiplier lifespan.

The second is the split between quantitation and identification. Selected ion monitoring (SIM) watches only target ions. Labs that want low-level SIM numbers for target compounds plus a library-searchable full scan for unknowns have run separate injections or built segmented methods by hand. MassHunter 14's Simultaneous dSIM/Scan mode captures both in a single analysis. Two injections become one.

Two more software pieces go after analyst time. Dynamic SIM automates SIM time segments, maximizing dwell time for sensitivity and peak shape so no one has to build retention windows by hand. Optimizer creates, updates and maintains SIM methods as compound databases grow. It targets the manual review work that would otherwise expand with every analyte list a lab adds. According to Agilent, the 5987A scans up to 25 percent faster than the company's earlier GC/MSD systems. Faster scanning sharpens narrow peaks and supports cleaner spectral library matches.

These are vendor-reported figures, and Lab Manager's review is careful to say the dynamic range pays off only if the gains hold in routine use. The direction of the design is still plain. The 5987A's most consequential features are the ones that take injections out of a sample's path, because at the helium prices Lab Manager describes, every avoided rerun saves gas as well as analyst hours.

Which feature matters first depends on the sample mix. A lab whose samples swing widely in concentration would feel the dynamic range first; a lab that injects twice to get both target quantitation and unknown screening would feel the dSIM/Scan mode first. A lab running SIM-only methods on samples with narrow, stable concentrations gains less from either, and its case rests on diagnostics and running costs.

GC Assist and the batch that fails at 2 a.m.

The third source of reruns is the fault nobody saw coming. On a previous-generation system, the operator usually spots drift only after a quality control check fails. GC Assist watches more than 60 parameters across the GC/MS workflow and flags results that fall outside predefined QC limits. When maintenance is due, it guides staff using onboard videos and step-by-step procedures. The software also monitors power and gas consumption and looks for carrier gas leak indicators, with remote monitoring and troubleshooting running inside the lab's secure network.

Warren Potts, vice president and general manager of Agilent's Gas Phase Division, framed the launch around labs carrying growing workloads with limited resources. In his telling, the built-in intelligence exists to surface potential issues earlier, simplify routine maintenance and keep scientists on their analytical work.

Diagnostics don't pay back evenly, though. Labs that already buy comprehensive service coverage may find GC Assist mostly changes which contract tier makes sense, Lab Manager noted, while labs running reactive maintenance get the biggest gain: an earlier warning before a failed QC check stalls a batch. The review adds that remote troubleshooting trims response time further, an advantage that would count most in a lab with no service engineer on call. That suggests the lab's own failure history, more than any spec, is the best predictor of whether the diagnostics earn their price.

Helium, hydrogen and the power bill

Agilent states that, paired with the IDP-4 pump, the 5987A uses up to 40 percent less energy than the company's earlier GC/MSD systems. Anyone scoring bids should note that condition. A quote built on a different pump configuration is not the quote the 40 percent figure describes.

The platform carries My Green Lab's ACT label, awarded after an independent environmental audit, and supports hydrogen carrier gas, which labs are evaluating as a helium alternative. Lab Manager reports both factors now appear in procurement scoring as well as sustainability reports. Its advice is to treat the vendor-reported 25 percent scan and 40 percent energy figures, along with hydrogen support, as total cost of ownership inputs rather than footnotes.

GC Assist's gas tracking belongs in the same ledger. Lab Manager says the leak-indicator monitoring carries real financial weight while labs are working through practical responses to the helium shortage. So the leak alerts could reasonably sit next to the energy figure in a running-cost estimate rather than in the service column.

Verification before the first reported result

None of this shortens onboarding. For regulated environmental work, the US Environmental Protection Agency sets acceptance criteria rather than mandating hardware. SW-846 Method 8270E for semivolatiles and Method 8260D for volatiles both run on single quadrupole GC/MS, so a lab bringing in a 5987A has to show the new system meets EPA performance criteria before it goes into service.

Accredited labs have a second step: method verification records under ISO/IEC 17025:2017 before they report results from the new platform. ISO's own description of the standard lists a reduced need for retesting among its benefits. That is the same outcome Agilent is selling, reached through documentation instead of hardware.

The practical upshot is timing. EPA criteria checks and 17025 verification runs consume analyst hours and instrument time of their own. A lab weighing the 5987A against its next capital cycle would do well to count those hours in first-year cost before it counts any rerun savings.

Why the upgrade stays in the single quad tier

A 2021 study in Analytical Chemistry by researchers at Scripps Research and Leiden University Medical Center described single quadrupole instruments as generally inexpensive, easy to operate and technically less complex. Triple quadrupole systems running multiple reaction monitoring remain the gold standard for small-molecule quantitation, the authors wrote, but they are typically expensive. The team's single quad quantitation approach came in at roughly 30 percent of the cost of MRM, with dynamic range of up to five orders of magnitude, comparable to the triple quad.

The authors also explain where some of that gap comes from. In MRM, the first quadrupole isolates a precursor ion and a collision cell fragments it, and that collision chamber brings inherent sensitivity losses. A single quad has no collision cell, so it avoids those ion losses.

That work covered LC/MS with enhanced in-source fragmentation, a different technique from the 5987A's GC work, so its numbers don't transfer directly. Still, the authors call their method a variation on an approach long used for high-sensitivity small-molecule quantitation with gas chromatography MS, which is the 5987A's home turf. What the study shows is the cost gap that keeps single quads on the bench for targeted analysis. For labs whose methods, such as 8270E and 8260D, already run on single quad GC/MS, the purchase stays inside that tier, and the 5987A competes on what it does to rerun rates and running costs.

The number that would settle the case doesn't appear on any spec sheet: rerun rates at labs that have run the 5987A through a full budget cycle, measured against the instrument it replaced. Labs that start counting their reruns by cause now will have their own answer ready when the replacement request reaches the budget committee.